Back to Search
Start Over
GP73 contributes to the sensitivity of cisplatin in esophageal cancer
- Source :
- Esophagus. 6:173-176
- Publication Year :
- 2009
- Publisher :
- Springer Science and Business Media LLC, 2009.
-
Abstract
- Background The prognosis of esophageal cancer patients is poor. Cisplatin (CDDP) is most often used for advanced esophageal cancer; however, the emergence of drug resistance has prevented successful treatment in many cases.
Details
- ISSN :
- 16129067 and 16129059
- Volume :
- 6
- Database :
- OpenAIRE
- Journal :
- Esophagus
- Accession number :
- edsair.doi...........64c253e151b4341e058a258348090a38
- Full Text :
- https://doi.org/10.1007/s10388-009-0201-4